IPHA News
December 9, 2024
The Irish Pharmaceutical Healthcare Association (IPHA), the representative body for the research-based biopharmaceutical industry in Ireland, has launched new features on the IPHA website which further […]
October 21, 2024
Let’s give every patient in Ireland the chance to create new memories. Pfizer, Novo Nordisk, Roche and AbbVie feature in IPHA’s campaign which highlights how, […]
October 1, 2024
36 new IPHA medicines planned for 2025 has the potential to benefit up to 3,700 patients and funding will now ensure access to these advances in medicines […]
September 11, 2024
Central to IPHA’s General Election manifesto is an ask for the next Government to commit to a continuous and faster flow of new life-enhancing medicines, and vaccines, for patients in Ireland. The manifesto outlines innovative proposals on how this can be achieved.
September 11, 2024
Shane Ryan, General Manager for Takeda Ireland, takes the mantle as President of the Irish Pharmaceutical Healthcare Association (IPHA) Central to his presidency, Shane Ryan pledges […]
August 20, 2024
The shared ambition of IPHA member companies is to make available life-enhancing medicines including vaccines, for patients in Ireland via those entitled to prescribe and supply. In […]
August 7, 2024
On June 28th, IPHA published the Transfer of value (ToV) Disclosure data for 2023. The total ToV amount for 2023 was €29,039,301 which is a 10% […]
July 30, 2024
IPHA members expect to make applications for reimbursement for 36 medicines in 2025, benefitting as many as 3,700 patients in Ireland. The funding of new medicines […]
July 22, 2024
The IPHA Annual Conference and dinner will take place at the Dublin Royal Convention Centre on Wednesday 26th February, 2025. Further details will be announced later. […]